Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan
{"title":"一项评估brentuximab vedotin联合环磷酰胺、阿霉素、依托泊苷和强的松(BV-CHEP)治疗侵袭性成人t细胞白血病/淋巴瘤的多中心试点研究的最终结果。","authors":"Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan","doi":"10.1111/bjh.20177","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":"207 1","pages":"299-303"},"PeriodicalIF":3.8000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma\",\"authors\":\"Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan\",\"doi\":\"10.1111/bjh.20177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\"207 1\",\"pages\":\"299-303\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bjh.20177\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bjh.20177","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma
期刊介绍:
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.